PH23325A - Phenyl carbamates - Google Patents
Phenyl carbamatesInfo
- Publication number
- PH23325A PH23325A PH33465A PH33465A PH23325A PH 23325 A PH23325 A PH 23325A PH 33465 A PH33465 A PH 33465A PH 33465 A PH33465 A PH 33465A PH 23325 A PH23325 A PH 23325A
- Authority
- PH
- Philippines
- Prior art keywords
- phenyl carbamates
- sub
- carbamates
- phenyl
- pharmaceuticals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/14—Dithiocarbamic acids; Derivatives thereof
- C07C333/30—Dithiocarbamic acids; Derivatives thereof having sulfur atoms of dithiocarbamic groups bound to other sulfur atoms
- C07C333/32—Thiuramsulfides; Thiurampolysulfides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL74497A IL74497A (en) | 1985-03-05 | 1985-03-05 | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PH23325A true PH23325A (en) | 1989-07-14 |
Family
ID=11055728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH33465A PH23325A (en) | 1985-03-05 | 1986-02-28 | Phenyl carbamates |
Country Status (25)
Country | Link |
---|---|
US (1) | US4948807A (sv) |
EP (1) | EP0193926B3 (sv) |
JP (1) | JPS61225158A (sv) |
KR (1) | KR940010764B1 (sv) |
AT (1) | ATE58130T1 (sv) |
AU (1) | AU595504B2 (sv) |
CA (1) | CA1284501C (sv) |
CY (2) | CY1748A (sv) |
DE (2) | DE3675408D1 (sv) |
DK (1) | DK172851B1 (sv) |
ES (1) | ES8801193A1 (sv) |
FI (1) | FI87197C (sv) |
GR (1) | GR860586B (sv) |
HK (1) | HK130293A (sv) |
HU (1) | HU201297B (sv) |
IE (1) | IE58838B1 (sv) |
IL (1) | IL74497A (sv) |
LU (1) | LU90312I2 (sv) |
MY (1) | MY137602A (sv) |
NL (1) | NL980031I2 (sv) |
NZ (1) | NZ215348A (sv) |
PH (1) | PH23325A (sv) |
PL (1) | PL146301B1 (sv) |
PT (1) | PT82127B (sv) |
ZA (1) | ZA861653B (sv) |
Families Citing this family (80)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH667001A5 (de) * | 1985-09-03 | 1988-09-15 | Hugo Degen | Untermatratze. |
HU201906B (en) * | 1987-03-04 | 1991-01-28 | Sandoz Ag | Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them |
DE3805744C2 (de) * | 1987-03-04 | 1999-09-23 | Novartis Ag | Phenylcarbamate zur Hemmung der Acetylcholinesterase |
US5091583A (en) * | 1990-05-07 | 1992-02-25 | Air Products And Chemicals, Inc. | Tertiary amine catalysts for polurethanes |
IT1271679B (it) * | 1994-07-18 | 1997-06-04 | Mediolanum Farmaceutici Srl | Derivati del fenilcarbammato atti all'impiego come anticolinesterasici |
US20100210590A1 (en) * | 1995-09-27 | 2010-08-19 | Northwestern University | Compositions and treatments for seizure-related disorders |
US5965571A (en) * | 1996-08-22 | 1999-10-12 | New York University | Cholinesterase inhibitors for treatment of Parkinson's disease |
IL130528A (en) | 1996-12-18 | 2004-12-15 | Teva Pharma | Aminoindan derivatives, pharmaceutical compositions comprising them and uses thereof |
DE69725467T2 (de) * | 1996-12-18 | 2004-07-22 | Teva Pharmaceutical Industries Ltd. | Phenylethylamin-derivate |
US6251938B1 (en) | 1996-12-18 | 2001-06-26 | Teva Pharmaceutical Industries, Ltd., | Phenylethylamine derivatives |
EP0952826B1 (en) * | 1997-01-17 | 2001-11-14 | Takeda Chemical Industries, Ltd. | Idebenone containing combination agent for treating alzheimer's disease |
US5962535A (en) * | 1997-01-17 | 1999-10-05 | Takeda Chemical Industries, Ltd. | Composition for alzheimer's disease |
GB9716879D0 (en) * | 1997-08-08 | 1997-10-15 | Shire Int Licensing Bv | Treatment of attention deficit disorders |
US6316023B1 (en) * | 1998-01-12 | 2001-11-13 | Novartis Ag | TTS containing an antioxidant |
AU1738800A (en) * | 1998-11-23 | 2000-06-13 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
GB9923045D0 (en) * | 1999-09-29 | 1999-12-01 | Novartis Ag | New oral formulations |
US6534541B1 (en) | 1999-10-19 | 2003-03-18 | Novartis Ag | Treatment of ocular disorders |
HUP0301794A3 (en) | 2000-01-28 | 2011-04-28 | Martek Biosciences Corp | Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
US20030153598A1 (en) * | 2000-07-25 | 2003-08-14 | Raymond Pratt | Methods for treating Parkinson's disease with cholinesterase inhibitors |
EP2140868A1 (en) * | 2000-03-03 | 2010-01-06 | Eisai R&D Management Co., Ltd. | Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments associated with or caused by chemotherapy |
AU5702201A (en) * | 2000-04-13 | 2001-10-30 | Mayo Foundation | Abeta<sub>42</sub> lowering agents |
GB0126378D0 (en) * | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
US20040010038A1 (en) * | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
US7385076B2 (en) | 2002-05-31 | 2008-06-10 | Sun Pharmaceutical Industries Limited | Process for the preparation of phenylcarbamates |
BRPI0311780B8 (pt) | 2002-06-14 | 2021-05-25 | Toyama Chemical Co Ltd | composição farmacêutica para melhorar a função cerebral |
EP1558591B1 (en) | 2002-10-07 | 2014-05-07 | The Regents of The University of California | Modulation of anxiety through blockade of anandamide hydrolysis |
CZ293014B6 (cs) * | 2002-10-24 | 2004-01-14 | Léčiva, A.S. | Způsob výroby (-)-(S)-3-[1-(dimethylamino)ethyl]fenyl-N-ethyl-N-methylkarbamátu |
DE10301851A1 (de) * | 2003-01-17 | 2004-07-29 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel |
WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
AU2004311577A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
EP1689704A2 (en) * | 2003-10-21 | 2006-08-16 | CoLucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
WO2005051919A1 (en) | 2003-11-26 | 2005-06-09 | Pfizer Products Inc. | Aminopyrazole derivatives as gsk-3 inhibitors |
GB0329284D0 (en) * | 2003-12-18 | 2004-01-21 | Avecia Ltd | Process |
GB2409453A (en) * | 2003-12-24 | 2005-06-29 | Generics | Process for the preparation of aminoalkyl phenylcarbamates |
US20050222123A1 (en) | 2004-01-27 | 2005-10-06 | North Shore-Long Island Jewish Research Institute | Cholinesterase inhibitors for treating inflammation |
WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006050359A2 (en) * | 2004-11-02 | 2006-05-11 | Northwestern University | Pyridazine compounds and methods |
JP4954886B2 (ja) * | 2004-11-08 | 2012-06-20 | エムキュア ファーマシューティカルズ リミテッド | (s)−3−[(1−ジメチルアミノ)エチル]−フェニル−n−エチル−n−メチル−カルバミン酸の効率的製造方法 |
AP2007003979A0 (en) * | 2004-11-23 | 2007-06-30 | Warner Lambert Co | 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia |
US7619007B2 (en) | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
MX2007012374A (es) | 2005-04-06 | 2008-02-22 | Adamas Pharmaceuticals Inc | Metodos y composiciones para el tratamiento de condiciones relacionadas con cns. |
US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
ES2267399B1 (es) | 2005-08-04 | 2008-02-01 | Ragactives, S.L. | Procedimiento para la obtencion de carbamatos de fenilo. |
AU2006326642B2 (en) * | 2005-12-09 | 2012-05-03 | Technion Research And Development Foundation Ltd. | Use of low-dose ladostigil for neuroprotection |
TW200744576A (en) * | 2006-02-24 | 2007-12-16 | Teva Pharma | Propargylated aminoindans, processes for preparation, and uses thereof |
US7767843B2 (en) * | 2006-03-02 | 2010-08-03 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
CA2650711A1 (en) * | 2006-04-28 | 2007-11-08 | Northwestern University | Compositions and treatments using pyridazine compounds and cholinesterase inhibitors |
US20080033045A1 (en) * | 2006-07-07 | 2008-02-07 | Myriad Genetics, Incorporated | Treatment of psychiatric disorders |
EP2054373B1 (en) * | 2006-08-17 | 2010-06-30 | Alembic Limited | Improved process for the preparation of rivastigmine |
WO2008037433A1 (en) | 2006-09-29 | 2008-04-03 | Synthon B.V. | Process for making aminoalkylphenyl carbamates and intermediates therefor |
EP2420235A1 (en) | 2006-10-27 | 2012-02-22 | Medivation Neurology, Inc. | Methods and combination therapies for treating alzheimer's disease |
CA2677241A1 (en) | 2007-02-02 | 2008-08-14 | Colucid Pharmaceuticals, Inc. | Compounds that inhibit cholinesterase |
US8013181B2 (en) | 2007-04-10 | 2011-09-06 | Dr. Reddy's Laboratories Limited | Preparation of rivastigmine and its salts |
WO2008124969A1 (fr) * | 2007-04-16 | 2008-10-23 | Topharman Shanghai Co., Ltd. | Méthode de préparation de rivastigmine et de ses intermédiaires |
US7884121B2 (en) | 2007-06-11 | 2011-02-08 | Apotex Pharmachem Inc. | Process for the preparation of phenylcarbamates |
CN101795683A (zh) * | 2007-07-18 | 2010-08-04 | 科露西德医药品公司 | 用于促进警醒症的方法 |
US8593728B2 (en) * | 2009-02-19 | 2013-11-26 | Toyota Motor Engineering & Manufacturing North America, Inc. | Multilayer photonic structures |
WO2010023535A1 (en) | 2008-08-25 | 2010-03-04 | Jubilant Organosys Limited | A process for producing (s)-3-[(1-dimethylamino)ethyl] phenyl-n-ethyl-n-methyl-carbamate via novel intermediates |
US8247405B2 (en) | 2008-12-10 | 2012-08-21 | Conopco, Inc. | Skin lightening compositions with acetylcholinesterase inhibitors |
CN101580482B (zh) * | 2009-05-27 | 2014-04-23 | 沈阳药科大学 | 一种重酒石酸盐卡巴拉汀的制备方法和应用 |
ES2363395B1 (es) * | 2010-01-20 | 2012-02-23 | Farmalider, S.A. | Composición farmacéutica l�?quida de rivastigmina o de una de sus sales de adición de �?cido para la administración por v�?a oral. |
CN102134206B (zh) * | 2010-01-27 | 2013-11-20 | 上海京新生物医药有限公司 | 一种卡巴拉汀的制备方法 |
EP2533645B1 (en) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
WO2011151669A1 (en) | 2010-06-02 | 2011-12-08 | Jubilant Life Sciences Limited | Process for producing enantiomerically enriched isomer of 3-(1-aminoethyl) phenyl derivative and employing the same to produce rivastigmine or its pharmaceutically acceptable salt |
US8852900B2 (en) | 2010-06-17 | 2014-10-07 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (S)-3-(1-aminoethyl)-phenol |
WO2012131699A1 (en) | 2011-03-30 | 2012-10-04 | Neon Laboratories Ltd. | Process for preparation of highly pure 3-dimethylaminophenyl dimethylcarbamate |
CN102786441B (zh) * | 2011-05-18 | 2013-11-13 | 浙江海正药业股份有限公司 | 利凡斯的明的制备方法、其中间体以及中间体的制备方法 |
WO2013155506A1 (en) | 2012-04-14 | 2013-10-17 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
ES2449215B1 (es) * | 2012-09-17 | 2014-07-14 | Galenicum Health S.L. | Solución oral de (S)-3-[1-(dimetilamino)etil]fenil N-etil-N-metilcarbamato |
EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA |
EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
DK2968220T3 (da) | 2013-03-15 | 2021-06-14 | Agenebio Inc | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
TW201540301A (zh) | 2013-08-16 | 2015-11-01 | Takeda Gmbh | 以pde4抑制劑治療認知損傷 |
BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
KR20200035359A (ko) | 2018-09-26 | 2020-04-03 | 캐딜라 파마슈티클즈 리미티드 | 리바스티그민 제조용 중간체의 합성 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1905990A (en) * | 1931-01-02 | 1933-04-25 | Hoffmann La Roche | Disubstituted carbamic acid esters of phenols containing a basic constituent |
US2208485A (en) * | 1937-04-24 | 1940-07-16 | Hoffmann La Roche | Process for the manufacture of disubstituted carbamic acid esters of phenols containing a basic substituent |
US2362508A (en) * | 1940-12-06 | 1944-11-14 | Merck & Co Inc | Therapeutic substances |
US2493710A (en) * | 1947-03-21 | 1950-01-03 | Hoffmann La Roche | Carbamic acid esters |
DE1037753B (de) * | 1956-07-13 | 1958-08-28 | Rohm & Haas | Schaedlingsbekaempfungsmittel |
-
1985
- 1985-03-05 IL IL74497A patent/IL74497A/xx not_active IP Right Cessation
-
1986
- 1986-02-28 PH PH33465A patent/PH23325A/en unknown
- 1986-03-03 PT PT82127A patent/PT82127B/pt unknown
- 1986-03-03 GR GR860586A patent/GR860586B/el unknown
- 1986-03-03 IE IE55886A patent/IE58838B1/en not_active IP Right Cessation
- 1986-03-03 NZ NZ215348A patent/NZ215348A/en unknown
- 1986-03-03 HU HU86870A patent/HU201297B/hu unknown
- 1986-03-04 DK DK198600991A patent/DK172851B1/da not_active IP Right Cessation
- 1986-03-04 ES ES552627A patent/ES8801193A1/es not_active Expired
- 1986-03-04 JP JP61048183A patent/JPS61225158A/ja active Granted
- 1986-03-04 KR KR1019860001491A patent/KR940010764B1/ko not_active IP Right Cessation
- 1986-03-04 EP EP86102812A patent/EP0193926B3/en not_active Expired - Lifetime
- 1986-03-04 DE DE8686102812T patent/DE3675408D1/de not_active Expired - Lifetime
- 1986-03-04 AT AT86102812T patent/ATE58130T1/de active
- 1986-03-04 FI FI860914A patent/FI87197C/sv not_active IP Right Cessation
- 1986-03-04 PL PL1986258224A patent/PL146301B1/pl unknown
- 1986-03-04 DE DE1998175046 patent/DE19875046I1/de active Pending
- 1986-03-05 ZA ZA861653A patent/ZA861653B/xx unknown
- 1986-03-05 AU AU54284/86A patent/AU595504B2/en not_active Expired
- 1986-03-05 CA CA000503306A patent/CA1284501C/en not_active Expired - Lifetime
-
1987
- 1987-09-25 MY MYPI87003119A patent/MY137602A/en unknown
-
1989
- 1989-03-08 US US07/320,700 patent/US4948807A/en not_active Expired - Lifetime
-
1993
- 1993-11-25 HK HK1302/93A patent/HK130293A/xx not_active IP Right Cessation
-
1994
- 1994-06-03 CY CY174894A patent/CY1748A/xx unknown
-
1998
- 1998-11-04 LU LU90312C patent/LU90312I2/xx unknown
- 1998-11-05 NL NL980031C patent/NL980031I2/nl unknown
-
2004
- 2004-10-27 CY CY200400004C patent/CY2004004I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1748A (en) | Phenyl carbamates | |
IT8520161A0 (it) | Composizioni per cosmesi comprendenti perfluoropolieteri. | |
DE3684564D1 (de) | Veterinaere zusammensetzungen. | |
DE3583852D1 (de) | Naehrstoffzusammensetzungen. | |
AU582369B2 (en) | Aminophenol compounds | |
ES8707253A1 (es) | Procedimiento para preparar sialosilcerebrosido gm4 | |
ES8800910A1 (es) | Un procedimiento para la preparacion de nuevas quinazolindionas | |
IT8521212A0 (it) | Composizioni covulcanizzabili di fluoroelastomeri. | |
PH23506A (en) | 1-aralkyl-substituted-1,2,4,-triazole-5-thiols as dopamine- -hydroxylase inhibitors | |
DE3581238D1 (de) | Mikrobiologische herstellung von l-phenylalanin. | |
AU585279B2 (en) | Pesticidal biphenylyloxy and biphenylylalkoxy aryl acyl urea compounds | |
IT8720012A0 (it) | Composizione anticorrosione. | |
ES8708132A1 (es) | Procedimiento para preparar n-fenil-4-fenil-1-piperazincarboxamidinas y compuestos afines como agentes anti-arritmicos | |
SU1220180A1 (ru) | Установка для массообмена | |
IT8422675A0 (it) | Un inoculo per la fermentazione procedimento per la produzione di anaerobica di coenzina b 12. | |
SU1258083A1 (ru) | Сталь | |
SU1269465A1 (ru) | Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов | |
SU1263148A1 (ru) | Интегральная микросхема | |
SU1297428A1 (ru) | 54, 56:58, 60-дииндий (iii) дихлор-6, 11:19, 24:32, 37:45, 50-тетраимино-5-, 52:13, 18:20, 31:39, 44-тетранитрилоктабензо [с, д, е, р, и, у, d, h] (1, 10, 19, 28) - тетраазациклогексатриаконтин как полупроводник | |
SU1271111A1 (ru) | Сплав на основе алюминия | |
SG120793G (en) | Phenyl carbamates. | |
GB8925435D0 (en) | The production of lak cells,compositions containing them,and their use | |
SU1055108A1 (ru) | 5,6-диоксим-2-п-метоксифенацилтетрагидро- 3,4,5,6-пиразинон-3, обладающий противовоспалительной активностью |